The development and pathogenesis of atherosclerosis are significantly influenced by
lifestyle, particularly nutrition. The modern level of science and technology development …

Introduction: Cardiovascular diseases (CVD) are the leading cause of global mortality and
morbidity. Current CVD treatment methods include dietary intervention, statins, fibrates …

Results: L. reuteri NCIMB 30242 capsules reduced LDL-C by 11.64%(P< 0.001), total
cholesterol by 9.14%,(P< 0.001), non-HDL-cholesterol (non-HDL-C) by 11.30%(P< 0.001) …

The gut microbiota has been increasingly linked to metabolic health and disease over the
last few decades. Several factors have been suggested to be involved in lipid metabolism …

Atherosclerosis, the underlying cause of cardiovascular diseases such as myocardial
infarction, cerebrovascular accident, and peripheral vascular disease, is the leading cause …

Thanks to recent scientific progress a relationship between the intestinal microbiota and
metabolic diseases could be established. A deeper understanding of underlying …

In this study, we hypothesized that different strains of Lactobacillus can alleviate
hyperlipidemia and liver steatosis via activation of 5′ adenosine monophosphate-activated …

Hypercholesterolemia is the main cause of cardiovascular disease worldwide, and the
regulation of cholesterol homeostasis is essential for human health. Lactobacillus is present …

Fucosterol, a sterol that is abundant in marine algae, has hypocholesterolemic activity, but
the mechanism underlying its effect is not clearly understood. Because data suggest that …

This study was designed to select potent cholesterol-lowering probiotic strains on HepG2
cell and investigate the effect of selected strain, Lactobacillus plantarum LRCC 5273 and …